• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
To complete, or not to complete, that is the question of revascularization in percutaneous coronary intervention with drug-eluting stents for multivessel disease.完成，还是不完成，这就是药物洗脱支架用于多支血管疾病经皮冠状动脉介入治疗中血管重建的问题。
J Thorac Dis. 2016 Nov;8(11):3034-3039. doi: 10.21037/jtd.2016.11.103.
2
One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.药物洗脱支架植入治疗多支冠状动脉疾病的一年临床结果及总成本
J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):596-601. doi: 10.2459/JCM.0b013e32801051f4.
3
Everolimus-eluting stents or bypass surgery for multivessel coronary disease.依维莫司洗脱支架或旁路手术治疗多支冠状动脉疾病。
N Engl J Med. 2015 Mar 26;372(13):1213-22. doi: 10.1056/NEJMoa1412168. Epub 2015 Mar 16.
4
Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients.未选择患者接受裸金属支架或药物洗脱支架多支血管经皮冠状动脉介入治疗后的三年生存率。
Am J Cardiol. 2009 Jan 15;103(2):203-11. doi: 10.1016/j.amjcard.2008.08.068. Epub 2008 Nov 19.
5
Hybrid coronary revascularization in the era of drug-eluting stents.药物洗脱支架时代的杂交冠状动脉血运重建术。
Ann Thorac Surg. 2004 Nov;78(5):1861-7. doi: 10.1016/j.athoracsur.2004.07.024.
6
[Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].[药物洗脱支架用于多支冠状动脉疾病：手术的重要堡垒之一被攻克了吗？]
Anadolu Kardiyol Derg. 2009 Aug;9(4):325-30.
7
One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI.生物可降解聚合物涂层依维莫司洗脱支架与耐久性聚合物涂层药物洗脱支架在 STEMI 伴多支血管病变患者中行罪犯血管或多支血管 PCI 中一年临床结局的比较。
Atherosclerosis. 2019 May;284:102-109. doi: 10.1016/j.atherosclerosis.2019.02.022. Epub 2019 Mar 3.
8
Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.接受药物洗脱支架经皮冠状动脉介入治疗的多支血管病变患者的完全血运重建与不完全血运重建
Catheter Cardiovasc Interv. 2008 Oct 1;72(4):448-56. doi: 10.1002/ccd.21666.
9
Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease.依维莫司洗脱支架与冠状动脉旁路移植术治疗糖尿病合并多支血管病变患者的疗效比较
Circ Cardiovasc Interv. 2015 Jul;8(7):e002626. doi: 10.1161/CIRCINTERVENTIONS.115.002626.
10
Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.多支冠状动脉疾病合并慢性肾脏病患者的血运重建：依维莫司洗脱支架与冠状动脉旁路移植术的比较
J Am Coll Cardiol. 2015 Sep 15;66(11):1209-1220. doi: 10.1016/j.jacc.2015.06.1334.

本文引用的文献

1
Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.药物洗脱支架治疗多支冠状动脉疾病患者的完全血运重建与不完全血运重建
Am Heart J. 2016 Sep;179:157-65. doi: 10.1016/j.ahj.2016.06.020. Epub 2016 Jul 7.
2
Survival after percutaneous coronary intervention for chronic total occlusion.经皮冠状动脉介入治疗慢性完全闭塞病变后的生存率。
Clin Res Cardiol. 2016 Nov;105(11):921-929. doi: 10.1007/s00392-016-1000-2. Epub 2016 Jun 1.
3
Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies.对于多支冠状动脉疾病的高危患者，采用先进技术进行完全心肌血运重建可带来更大的临床益处：一项对随机和观察性研究的荟萃分析。
Catheter Cardiovasc Interv. 2016 Jan 1;87(1):3-12. doi: 10.1002/ccd.25923. Epub 2015 Apr 2.
4
Long-term outcomes of complete versus incomplete revascularization for patients with multivessel coronary artery disease and left ventricular systolic dysfunction in drug-eluting stent era.药物洗脱支架时代多支冠状动脉疾病合并左心室收缩功能障碍患者完全血运重建与不完全血运重建的长期预后
J Korean Med Sci. 2014 Nov;29(11):1501-6. doi: 10.3346/jkms.2014.29.11.1501. Epub 2014 Nov 4.
5
A meta-analysis of adjusted risk estimates for survival from observational studies of complete versus incomplete revascularization in patients with multivessel disease undergoing coronary artery bypass grafting.一项关于接受冠状动脉搭桥术的多支血管疾病患者完全血运重建与不完全血运重建的观察性研究中生存调整风险估计值的荟萃分析。
Interact Cardiovasc Thorac Surg. 2014 May;18(5):679-82. doi: 10.1093/icvts/ivu012. Epub 2014 Feb 13.
6
Incomplete revascularization is associated with greater risk of long-term mortality after stenting in the era of first generation drug-eluting stents.在第一代药物洗脱支架时代，支架置入术后不完全血运重建与长期死亡率增加相关。
Am J Cardiol. 2013 Sep 15;112(6):775-81. doi: 10.1016/j.amjcard.2013.05.003. Epub 2013 Jun 4.
7
Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.多支血管病变患者完全血运重建与不完全血运重建的结局比较：随机临床试验和观察性研究中 89883 例患者的荟萃分析。
J Am Coll Cardiol. 2013 Oct 15;62(16):1421-31. doi: 10.1016/j.jacc.2013.05.033. Epub 2013 Jun 7.
8
Long-term outcomes of complete versus incomplete revascularization after drug-eluting stent implantation in patients with multivessel coronary disease.多支血管病变患者药物洗脱支架置入术后完全与不完全血运重建的长期结果。
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):343-9. doi: 10.1002/ccd.24799. Epub 2013 Apr 16.
9
Benefit of complete revascularization in patients with multivessel coronary disease in the drug-eluting stent era.药物洗脱支架时代多支血管病变患者完全血运重建的获益。
Circ J. 2012;76(7):1624-30. doi: 10.1253/circj.cj-11-1285. Epub 2012 Apr 14.
10
Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.经皮冠状动脉介入治疗和冠状动脉旁路移植术后不完全血运重建的发生率、预测因素和结局：SYNTAX 数据 3 年亚组分析。
Eur J Cardiothorac Surg. 2012 Mar;41(3):535-41. doi: 10.1093/ejcts/ezr105. Epub 2011 Dec 21.

To complete, or not to complete, that is the question of revascularization in percutaneous coronary intervention with drug-eluting stents for multivessel disease.

作者信息

Takagi Hisato, Ando Tomo, Umemoto Takuya

机构信息

Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.

Department of Cardiology, Detroit Medical Center, Detroit, MI, USA.

出版信息

J Thorac Dis. 2016 Nov;8(11):3034-3039. doi: 10.21037/jtd.2016.11.103.

DOI:10.21037/jtd.2016.11.103
PMID:28066576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5179470/
Abstract
摘要